RT Journal
A1 Breimer LH, Mikhailidis DP
T1 TRials by independent expert bodies
JF Archives of Internal Medicine
JO Archives of Internal Medicine
YR 2010
FD December 13
VO 170
IS 22
SP 2042
OP 2042
DO 10.1001/archinternmed.2010.457
UL http://dx.doi.org/10.1001/archinternmed.2010.457
AB 
Studies conducted by pharmaceutical companies for registration purposes are often constrained. An alternative would be to conduct more trials that are viewed as a priority by independent expert bodies but not necessarily by drug companies. These expert bodies could be funded by a small voluntary contribution collected from drug sales.